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Objective:  To validate a Parental Assessment of Children’s External genitalia scale for Females 
(PACE-F) for girls with Congenital Adrenal Hyperplasia (CAH) by adapting the validated adult 
Female Genital Self-Image Scale. 
 
Methods:  PACE-F was administered to parents of girls (Tanner 1, 2 months-12 years) with and 
without CAH.  Final questions were determined by clinical relevance and psychometric 
properties (scores: 0-100).  A reference range was established using 95% confidence interval 
among controls.  Age-matched controls were compared to girls with CAH a) <4 years old before 
and after Female Genital Reconstruction Surgery (FGRS), and b) 4-12 year olds after FGRS.  
Non-parametric statistics were used.  
 
Results: Participants included 56 parents of 41 girls with CAH (median 3.9 years old, 97.6% 
FGRS) and 139 parents of 130 girls without CAH.  Face and content validity was established by 
families, experts and factor analysis.  Internal consistency was high (Cronbach’s alpha: 0.83).  
Population reference score range was 66.7-100.  Ten consecutive girls had pre- and post-FGRS 
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PACE-F scores.  All scores improved at 4 months after surgery and all preoperative scores were 
below reference range and lower than controls (p=0.0001).  All post-operative scores were 
within reference range, no different from controls (p=0.18).  Scores for girls with CAH after 
FGRS aged 4-12 years were no different from controls (100.0 vs. 88.9, p=0.77) and 90.0% were 
in reference range, as expected (p=0.99).  
 
Conclusions: We present a validated instrument for parental assessment of genital appearance in 
girls with CAH.  We demonstrate improved parent-reported appearance after FGRS, with scores 
similar to age-matched controls.  
 
 
Abbreviations:  CAH: Congenital Adrenal Hyperplasia, FGRS: Female Genital Restoration 
Surgery, PRO: Patient-/Parent-Reported Outcome, FGSIS: Female Genital Self-Image Scale, 
PACE-F: Parental Assessment of Children’s External genitalia scale for Females, SD: Standard 
Deviation, MID: Minimal clinically Important Difference, SEM: Standard Error of 
Measurement, SRM: Standardized Response Mean, PUM: Partial Urogenital sinus Mobilization 
 
Introduction 
 
Congenital adrenal hyperplasia (CAH) is the most common etiology of ambiguous genitalia in 
newborns.
1-3
  The appropriateness and timing of female genital restoration surgery (FGRS) in 
females with CAH is an area of debate.
4,5
  Adding to ethical considerations are concerns that 
outcomes may differ for surgeries performed in infancy versus puberty.
6,7
  Limited data supports 
either approach.
8,9
  Since physician interpretations of patient and parental views are prone to 
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bias, under-reporting and minimization,
10,11
 validated methods of obtaining patient/parent-
reported outcomes (PROs) are necessary. 
 
While patient’s perceptions are essential, parents currently make the early management 
decisions.  Improved parental perception after FGRS has never been reliably documented in the 
literature.  Moreover, without a validated tool for such an assessment in girls with and without 
genital ambiguity, reliable studies of relationships between anatomy, parental perceptions and, 
most importantly, perceptions by females themselves cannot be performed.  The 4-item Female 
Genital Self-Image Scale (FGSIS) was validated in a large national sample of adult women 
without known genital ambiguity, measuring women’s perceptions about their genital 
appearance.
12
  Lack of an age-appropriate parental FGSIS version precludes its use in children 
with genital ambiguity.  We aimed 1) to validate a Parental Assessment of Children’s External 
genitalia scale for Females (PACE-F) for girls with CAH by adapting the FGSIS, and 2) to report 
preliminary results of the PACE-F in girls with CAH.  We hypothesized that PACE-F scores are 
lower for girls with CAH without FGRS than girls after FGRS and girls without CAH. 
 
Methods 
 
We performed an IRB-approved study of parents of girls (Tanner 1, 2 months-12 years old) with 
CAH at pediatric urology clinics and without CAH (controls) at pediatrician clinics and among 
hospital staff and colleagues (2016-2018).  Girls with CAH were followed at our institution 
before and after FGRS, all performed by age three largely by a single surgeon (2005-2018).  
Parents of 105 children with CAH with contact information were eligible.  Exclusion criteria for 
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control participants were: girls having diagnoses suggestive of abnormal genitalia/perineum or 
conditions predisposing to frequent genital examinations (genital concerns, history of urinary 
tract infections, hematuria, clean intermittent catheterizations, neurogenic bladder, imperforate 
anus). Controls presenting for routine checkup appointments received a $5 gift card.  
 
Instrument Development 
We used a step-wise approach to develop a brief, clinically useful instrument capturing parental 
perceptions of genital appearance of girls with CAH.  First, the 4-item FGSIS was reworded to 
be age-appropriate and reflect parental, rather than patient, responses.  It was revised after 
piloting with 4 parents and 6 clinicians.  Responses were made on a 4-point Likert scale 
(strongly disagree, disagree, agree, strongly agree), like the original FGSIS instrument.  
Readability was assessed by the Flesch-Kincaid Grade Level test.
13
 
 
Item reduction 
Item reduction is commonly performed to arrive at shorter instruments without compromising 
utility.  Each of the 4 reworded items was examined for medical plausibility, clinical relevance 
and parental comfort (“I am comfortable answering this question:” strongly disagree, disagree, 
agree, strongly agree; not validated).  We performed a principal axes method of factor analysis 
and inspection of the scree plot inflexion point.
14,15
  Since at least 3 items with loadings >0.4 
would be required for a functional instrument,
14,15
 one item could and was dropped.  Factor 
analysis was used to assess whether the original 4 items, or a reduced set of 3, reasonably 
satisfied unidimensionality.  Factor analysis of 4 items would require 20 participants (at least 5 
participants/item) for adequate statistical estimation.
16,17
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Validation 
Since PACE-F is a parent-reported measure, it was more appropriate to treat each parental 
response, rather than an individual child, as the unit of analysis during the validation.  We 
assessed several types of validity to determine if PACE-F measures what it was intended to 
measure.
18
  Face and content validity were established through a review by parents and experts.  
Construct validity was assessed through 1) factor analysis in the CAH group and 2) comparing 
PACE-F scores between children with and without CAH, regardless of history of FGRS.  We 
calculated the domain means, standard deviations (SD), medians, ranges and percentages of 
subjects scoring the minimum (floor) and maximum (ceiling).   
 
Reliability (reproducibility) was assessed by measuring internal consistency with Cronbach’s 
alpha (0.7-0.9 signifies robust consistency without redundancy).  Cronbach’s alpha for the 4-item 
FGSIS is 0.86.
12
 
 
Convergent validity evaluates the degree to which PACE-F scores converge with other 
instruments measuring similar outcomes or a gold standard.  No instrument similar to PACE-F 
exists, thus we compared PACE-F scores between parents expressing different levels of comfort 
with changing diapers in a public bathroom for children <4 years old (“I am comfortable 
changing my child's diapers in a public bathroom or change room:” strongly disagree, disagree, 
agree, strongly agree; not validated) and, when available, surgeon-assessed pre-FGRS level of 
virilization (Prader scale). 
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Clinical utility 
To determine a reference range of PACE-F values for future clinical use, we used the one-sided 
(lower) 95% confidence interval of scores from parents for girls without CAH, a method 
previously used by the World Health Organization.
19
  Two distribution-based approaches were 
used to determine the minimal clinically important difference (MID) in PACE-F scores that 
could be appreciated by individuals.  Differences were determined using 0.5 SD
20
 and 1.0 
standard error of measurement (SEM), where SEM was defined as SD*√(1-Cronbach’s 
alpha).
21,22
  We selected the most conservative, largest point difference calculated by these 
methods as the MID. 
 
Differences between parents 
Maternal and paternal PACE-F scores were compared to determine if parents provided similar 
scores for their daughter. 
 
Age-matched comparisons 
Since clinically meaningful analyses apply to individual patients, each child was the unit of 
analysis for each of the 3 comparisons between girls with CAH and age-matched controls.  
Because maternal and paternal PACE-F scores did not differ significantly (see Results), a mean 
of the two scores was used when both were provided.  Findings were similar when each analysis 
was repeated with parental scores as the unit of analysis (not shown). 
  
1) The first comparison included only girls with prospectively collected pre- and post-FGRS 
PACE-F scores.  In order to capture all post-FGRS PACE-F scores for patients whose surgery 
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occurred by the age of three, this analysis was restricted to girls younger than 4.  An association 
between post-FGRS changes in PACE-F scores and changes in levels of comfort changing 
diapers in a public bathroom was tested to assess sensitivity, or responsiveness, of PACE-F, 
another form of validity. 
 
2) The second analysis consisted of single-time point scores for girls <4 years old with only a 
pre- or post FGRS assessment.  
 
3) The third comparison included single time-point PACE-F scores of 4-12 year olds with CAH 
(all after FGRS) and controls.   
 
Sensitivity to change validity 
To quantify effect size observed in the prospective analysis, we calculated a standardized 
response mean (SRM) by dividing the mean change in scores by the SD of the change in 
scores.
23,24
  Effect size can be categorized as small (0.2-0.5), moderate (0.5-0.8) and large (>0.8). 
SRM can be helpful in future power calculations. 
 
Statistics 
Study data were managed using REDCap.
25
  Due to skewed score distributions, non-parametric 
statistics were used (Fisher’s exact test for categorical variables; Wilcoxon rank sum and 
Kruskal-Wallis rank tests for cross-sectional comparisons of continuous data; Wilcoxon 
matched-pairs signed-rank test to compare scores before/after surgery).  Factor analysis was 
used, as described above.  Linear regression was used to test if PACE-F scores varied with age 
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among controls. A critical p=0.05 was used (software: Stata, StataCorp, College Station, TX, 
USA). 
 
Results 
 
Overall, 56 parental questionnaires were completed for 41 girls with CAH (38.7% response rate).  
Nineteen questionnaires were for 14 girls <4 years old without FGRS and 37 were after FGRS 
(17 for girls <4 years old, 20 for girls 4-12 year).  Ten girls <4 years old had pre- and post-FGRS 
scores collected prospectively (23 parental responses, Analysis 1).  Eleven girls <4 years old (13 
parental responses) had either a pre-FGRS (4) or post-FGRS scores (7) (Analysis 2).  Twenty 
girls 4-12 years had post-FGRS scores from 20 parents (Analysis 3).  Fourteen of the last 15 
(93.3%) consecutive families assed at our institution participated. 
 
Median age of 41 girls with CAH was 3.9 years old at end of the study (95.1% salt-wasting 21-
hydroxylade deficiency).  Forty girls underwent FGRS at median age of 8 months (range: 2 to 37 
months; 1 did not have surgery) with a median follow-up 2.9 years.  Only one girl underwent 
surgery at another center.  Overall, 87.5% of girls underwent vaginoplasty (71.4% posterior skin 
flap, 20.0% posterior sinus flap, 8.6% pull-through), 92.5% partial urogenital sinus mobilization 
(PUM)
26
 and 95.0% clitoroplasty.  Preoperative Prader scale was documented for 21 girls:  
Prader 3 in 47.6%, 4 in 47.6% and 5 in 4.8%. 
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Regarding controls, 139 parents of 130 girls without CAH participated.  Parents in the CAH 
group were undistinguishable from parent controls in terms of age (36 vs. 36 years, p=0.59) and 
proportion being fathers (16.1% vs. 23.9%, p=0.26).  
 
Construct validity 
Like the original 4-item FGSIS, all PACE-F items loaded significantly on one factor, accounting 
for 87.4% of item variance.  Factor loadings were high for item 1 (satisfaction: 0.94), item 2 
(comfort: 0.97) and item 4 (embarrassment: 0.49).  Item 3 (“I think my child's genitals smell 
fine”), was not retained because it had a loading <0.4 (0.11), was least clinically relevant and 
least comfortable for parents to answer.  The scree plot indicated a single dominant dimension, 
especially after deleting Item 3. 
 
The final 3-item PACE-F has grade 7 readability, takes 1 minute to complete and is scored 0-
100, where higher values signify higher satisfaction (Table 1).  Median PACE-F score for the 
whole CAH groups was 66.7 (range 11.1-100.0), mean: 67.3 (SD 28.1) (Table 2).  A ceiling 
effect was observed, with 28.6% of responses being the maximal possible score of 100.  
Importantly, all scores for girls without FGRS were less than 100, indicating the ceiling effect 
applies only after FGRS (and to controls).  Without considering FGRS history, median scores 
were lower in CAH group than controls (p=0.0001). 
 
Internal reliability 
The initial 4-item PACE-F had a Cronbach’s alpha of 0.73 among parents of girls with CAH.  
After excluding the “smell item,” the Cronbach’s alpha for the 3-item PACE-F was 0.83, 
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suggesting improved internal consistency without redundancy.  Not surprisingly, the 3-item 
PACE-F Cronbach’s alpha for controls was 0.90, indicating that PACE-F items are redundant 
among parents of healthy girls. 
 
Convergent validity 
Stronger parental comfort changing diapers in a public bathroom was associated with higher 
PACE-F scores of girls with CAH <4 years old (p=0.03, Figure 1).  Among 13 girls with a 
documented pre-FGRS Prader grade and PACE-F scores, greater virilization was associated with 
slightly lower PACE-F scores, although this did not reach statistical significance.  This was true 
for individual parental scores (8 parents Prader 3: 44.4 vs. 11 Prader 4-5: 33.3, p=0.40) and 
average scores per child if both parents participated (6 children Prader 3: 38.5 vs. 7 Prader 4-5: 
33.3, p=0.36). 
 
Population reference range of PACE-F scores 
Median score for controls was 100, although 46.8% of parents reported lower scores (Table 2).  
The 95% confidence interval of scores was 66.7-100.0, meaning that scores below 66.7 would be 
considered outside of the population range.  PACE-F scores did not vary by child’s age in the 
first 12 years of life on linear regression (p=0.15) or between children younger than 4 and 4-12 
years old (p=0.11). 
 
Minimally important difference 
The minimally important difference in PACE-F scores that can be appreciated clinically was 
14.1 (14.1 for 0.5 SD, 11.6 for SEM using Cronbach’s alpha).  Since there are 10 possible scores 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 12 
for the 3-item PACE-F, each being 11.1 points apart, a difference of at least 22.2, but not 11.1 
would be perceivable to an individual. 
 
PACE-F scores reported by mothers and fathers 
Only 5 mother-father pairs provided individual pre-FGRS PACE-F scores, limiting comparison 
of the two parents.  Pairing these scores, mothers and fathers reported undistinguishable scores 
(median: 33.3 vs. 33.3, p=0.99). 
 
Prospective analysis: Girls <4 years old with CAH undergoing FGRS 
Baseline and post-operative PACE-F scores were available for 10 girls undergoing FGRS (23 
parental responses).  FGRS occurred at median 8 months old (80.0% vaginoplasty, 100.0% 
PUM, 100.0% clitoroplasty).  All scores improved at median 4 months after surgery (median: 
38.9 vs. 88.9, p=0.01, Figure 2).  Pre-FGRS scores were lower than age-matched controls 
(p=0.0001) and post-operative scores were undistinguishable from age-matched controls 
(p=0.18).  All scores improved from below to within the population reference range. 
 
Pre-operatively, parents of girls with CAH reported greater discomfort changing diapers in 
public compared to age-matched controls (p=0.0002).  Level of comfort improved after surgery 
(p=0.02) and was undistinguishable from age-matched controls (p=0.43).  After surgery, all 
parents of girls with CAH agreed/strongly agreed they were comfortable changing diapers.  
These findings indicate PACE-F is a sensitive instrument, responsive to change. 
 
Sensitivity to change validity (n=10) 
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After surgery, mean PACE-F scores increased by 47.2 (SD 16.8).  This signifies a large effect 
size (47.2/16.8=2.8). 
 
Cross-sectional analysis: Girls <4 years old with either a pre- or post-FGRS PACE-F score 
Eleven girls younger than 4 years old were included in this analysis (4 pre-, 7 post-FGRS, 13 
parental scores).  The 7 parents provided PACE-F scores at a median of 19 months after FGRS 
(85.7% vaginoplasty, 71.4% PUM, 85.7% clitoroplasty).  Median pre-FGRS scores were lower 
than post-FGRS scores (36.1 vs. 77.8, p=0.046).  Three of four pre-FGRS scores were below the 
population reference range and lower than the age-matched controls (median: 100.0, p=0.001).  
All post-FGRS scores were in the reference range, but lower than controls (p=0.01). 
 
Cross-sectional analysis: Girls 4-12 years old with CAH after FGRS 
Twenty PACE-F scores were available for 20 girls who underwent FGRS by the age of 3 (90.0% 
vaginoplasty, 95.0% PUM, 95.0% clitoroplasty) with a median follow-up of 7.8 years (median 
age 8.5 years).  Median scores were undistinguishable between girls with CAH and controls 
(100.0 vs. 88.9, respectively, p=0.77).  Two of 20 girls (10.0%) had PACE-F scores below the 
population reference range (22.2 and 33.3).  This was not statistically distinct from the expected 
1/20 (5%) of responses being below the 95% confidence interval-derived population reference 
range (p=0.99).  Both patients underwent a vaginoplasty and PUM without surgical 
complications in the first year of life.  One patient did not undergo a clitoroplasty at initial 
surgery and parents had concerns about clitoromegaly at age 6 (awaiting patient to make decision 
about further surgery).  Second patient underwent FGRS and was 5 years old at follow-up. 
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Discussion 
 
We present a validation of parent-reported genital appearance scale for use in pre-pubertal girls 
with CAH.  The genital appearance of infants and toddlers with CAH , per parents, is outside the 
population reference range.  Short-term prospective evidence indicates that genital appearance 
improves after FGRS.  Cross-sectional data suggests these results are maintained until puberty.   
 
Few PROs explicitly address issues of appearance and function associated with ambiguous 
genitalia in a way that is both sensitive and meaningful to patients, families and clinicians.  The 
validation of the parent-reported PACE-F is a necessary first step towards giving those living 
with CAH and their families a voice in an effort replace anecdote-based reporting with robust 
data. 
 
While following the statistical rigor of PRO validation, we wished to ensure that the resulting 
instrument was clinically meaningful.  For that reason, we determined the population reference 
range (“What is a reference to compare to?”) as well as the minimally important difference 
between scores (“What is a significant difference?”).  These characteristics are rarely established 
for PROs, restricting their real-life implementation.  It should be noted that scores derived using 
PACE-F, or other questionnaires, are intended to be only one of the tools to provide quality care.   
 
A single item question was not used as a final PRO.  First, a single item tends to have a limited 
scale, curbing its discrimination ability, sensitivity to change and usefulness in both clinical and 
research settings.  More importantly, a single item ignores potential multiple dimensions of a 
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single concept.  In this instance, parents of girls with CAH (and women who endorsed the 
original FGSIS items) submit that genital appearance encompasses aspects of not only 
satisfaction and embarrassment in general, but also comfort during future sexual contact in 
particular.  We believe a multi-item questionnaire better reflects this multi-faceted concept of 
female genital appearance. 
 
The mean PACE-F score for girls with CAH, including those without surgery, was 67.3 (SD 
28.1), similar to FGSIS scores (linearly transformed to 0-100) for the general population of adult 
women without known ambiguity (mean: 67.0, SD 21.7).  The PACE-F MID was 14, also 
similar to the FGSIS of 11 points.  While the MID for FGSIS is not published, it was derived 
using the approach outlined in the Methods section (10.8 for 0.5 SD, 8.1 for SEM using 
Cronbach’s alpha).  Undoubtedly, the two measures differ in who reports them and how many 
items they contain, but the similarity of scores informs us about women’s perceptions of their 
own genitalia.  It appears that healthy women experience (dis)satisfaction with their genital 
appearance comparable to parents of girls with CAH, begging the question of what women in the 
general population consider “normal” or “satisfactory.” 
 
Our study has several limitations.  Given its small size, further work is required to externally 
validate PACE-F in larger, particularly prospective, cohorts.  We did not assess test-retest 
reliability of PACE-F scores, although FGSIS has excellent test-retest reliability.
12
  This will be 
the focus of future work.  Despite noting a trend, we did not note a statistically significant 
correlation between the level of virilization and PACE-F scores.  This was most likely due to low 
statistical power.  Alternatively, it is plausible that parental perceptions of genital appearance 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 16 
may be more of a more binary phenomenon, rather than a gradient associated with levels of 
virilization. 
 
Correlations between parental and patient assessments of genital appearance remain unknown.  
How PACE-F scores relate to anatomical variables, including clitoral appearance, and functional 
outcomes requires a multi-institutional study.  Finally, since all older girls in our study 
underwent FGRS, it is crucial to note that no scientific data exist on how parents, girls and 
women with CAH who have not undergone FGRS perceive their genitalia. 
 
Conclusion 
 
We present a new, validated instrument for a parental assessment of genital appearance in girls 
with CAH.  We also demonstrate improvement in parent-reported appearance after FGRS, which 
appears to be similar to age-matched controls.  PACE-F may prove useful in clinical practice and 
research. 
 
Figure Legends:  
Figure 1.  PACE-F scores stratified by comfort with changing diapers in a public 
bathroom for parents of girls with CAH younger than 4 years old (p=0.03 test for trend, 
n=27). 
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Figure 2.  Parental Assessment of Children’s External genitalia scale for Females 
(PACE-F) for 10 girls with CAH prospectively administered before and after female 
genital restoration surgery. 
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Question 
Strongly 
disagree 
Disagree Agree 
Strongly 
agree 
1. I am satisfied with the way my 
child's genitals look. 
    
2. I would feel comfortable 
letting my child's future sexual 
partner look at her genitals when 
she is older. 
    
3. I am not embarrassed about 
my child's genitals. 
    
Table 1. Parental Assessment of Children’s External genitalia scale for Females 
(PACE-F).  Answers options are: strongly disagree (0.0), disagree (11.1), agree (22.2), 
strongly agree (33.3).  Final score range is: 0-100. 
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Parents of 
girls with 
CAH 
N 
Median age 
(years, range) 
Mean 
(SD) 
Median 
(range) 
% 
Scoring 
Minimum 
% 
Scoring 
Maximum 
Overall 56 
3.5 (6 months-
12.0 years) 
67.3 
(28.1) 
66.7 (11.1-
100.0) 
0.0 28.6 
Without 
FGRS 
19 
7 months (6 
months-3.1 
years) 
37.4 
(114.9) 
33.3 (11.1-
77.8) 
0.0 0.0 
After FGRS 
(Less than 4 
years) 
17 
14 months (11 
months-3.9 
years) 
81.1 
(13.5) 
77.8 (66.7-
100.0) 
0.0 23.5 
After FGRS 
(4-12 years) 
20 8.5 (4.3-12.0) 
83.9 
(23.8) 
100 (22.2-
100.0) 
0.0 60.0 
       
Parents of 
girls 
without 
CAH 
N 
Median age 
(range) 
Mean 
(SD) 
Median 
(Range) 
% 
Scoring 
Minimum 
% 
Scoring 
Maximum 
Overalla 139 
3.5 (2 months-
12.0) 
89.1 
(13.8) 
100.0 (55.6-
100.0) 
0.0 53.2 
Less than 4 
years 
68 
1.3 (2 months-
3.9) 
91.2 
(12.8) 
100 (55.6-
100.0) 
0.0 58.8 
4-12 years 71 6.1 (4.0-12.0) 86.8 88.9 (66.7- 0.0 48.4 
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(14.8) 100.0) 
Table 2.  Domain characteristics of the parent-reported PACE-F scores in girls with and 
without CAH. 
aNo statistically significant differences in scores were noted between different age 
groups. 
 
 
 
